

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.55766029 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.55766029 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.05098764 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.05098764 |
| 5 | axonemal dynein complex assembly (GO:0070286) | 4.94844155 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 4.61805419 |
| 7 | central nervous system myelination (GO:0022010) | 4.61805419 |
| 8 | fatty acid elongation (GO:0030497) | 4.51387698 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.38735878 |
| 10 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.34820537 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09515819 |
| 12 | bile acid biosynthetic process (GO:0006699) | 3.79913761 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.73918096 |
| 14 | glyoxylate metabolic process (GO:0046487) | 3.66071632 |
| 15 | motile cilium assembly (GO:0044458) | 3.58518810 |
| 16 | cysteine metabolic process (GO:0006534) | 3.54908864 |
| 17 | response to methylmercury (GO:0051597) | 3.54498325 |
| 18 | desmosome organization (GO:0002934) | 3.52201788 |
| 19 | very long-chain fatty acid metabolic process (GO:0000038) | 3.46799399 |
| 20 | vitamin transmembrane transport (GO:0035461) | 3.45355749 |
| 21 | cilium movement (GO:0003341) | 3.43225385 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 3.40206159 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 3.39973988 |
| 24 | bile acid metabolic process (GO:0008206) | 3.36000134 |
| 25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.34711563 |
| 26 | tryptophan catabolic process (GO:0006569) | 3.34008326 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 3.34008326 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 3.34008326 |
| 29 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.31748844 |
| 30 | cholesterol biosynthetic process (GO:0006695) | 3.30903657 |
| 31 | glutamate metabolic process (GO:0006536) | 3.29818786 |
| 32 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.29195068 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.24428337 |
| 34 | lung epithelium development (GO:0060428) | 3.22720662 |
| 35 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.20957357 |
| 36 | coenzyme catabolic process (GO:0009109) | 3.20599805 |
| 37 | ethanol metabolic process (GO:0006067) | 3.20372355 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 3.19499009 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.17059013 |
| 40 | tyrosine metabolic process (GO:0006570) | 3.16880737 |
| 41 | protein carboxylation (GO:0018214) | 3.14763069 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.14763069 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 3.13646636 |
| 44 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.13355660 |
| 45 | primary alcohol catabolic process (GO:0034310) | 3.11325702 |
| 46 | axon ensheathment (GO:0008366) | 3.09754965 |
| 47 | ensheathment of neurons (GO:0007272) | 3.09754965 |
| 48 | regulation of fibrinolysis (GO:0051917) | 3.09274206 |
| 49 | myelination (GO:0042552) | 3.08892928 |
| 50 | cholesterol efflux (GO:0033344) | 3.08663037 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.05378310 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 3.02415200 |
| 53 | urea cycle (GO:0000050) | 3.02031670 |
| 54 | urea metabolic process (GO:0019627) | 3.02031670 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.01144422 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 2.98794439 |
| 57 | hemidesmosome assembly (GO:0031581) | 2.98456736 |
| 58 | short-chain fatty acid metabolic process (GO:0046459) | 2.96655540 |
| 59 | sodium ion export (GO:0071436) | 2.95281478 |
| 60 | ketone body metabolic process (GO:1902224) | 2.92652036 |
| 61 | multicellular organismal water homeostasis (GO:0050891) | 2.92087826 |
| 62 | sodium ion homeostasis (GO:0055078) | 2.90309611 |
| 63 | acyl-CoA biosynthetic process (GO:0071616) | 2.89628129 |
| 64 | thioester biosynthetic process (GO:0035384) | 2.89628129 |
| 65 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.87059307 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 2.86963005 |
| 67 | sterol biosynthetic process (GO:0016126) | 2.86144757 |
| 68 | regulation of triglyceride catabolic process (GO:0010896) | 2.85637774 |
| 69 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.85470688 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 2.84445118 |
| 71 | macromolecular complex remodeling (GO:0034367) | 2.84445118 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84445118 |
| 73 | acetyl-CoA metabolic process (GO:0006084) | 2.84149403 |
| 74 | cerebellar granule cell differentiation (GO:0021707) | 2.83703195 |
| 75 | complement activation, alternative pathway (GO:0006957) | 2.83495292 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 2.82895028 |
| 77 | triglyceride homeostasis (GO:0070328) | 2.82577753 |
| 78 | acylglycerol homeostasis (GO:0055090) | 2.82577753 |
| 79 | drug catabolic process (GO:0042737) | 2.81142272 |
| 80 | heme transport (GO:0015886) | 2.80787272 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.80697493 |
| 82 | regulation of protein activation cascade (GO:2000257) | 2.78104601 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.75868273 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.75868273 |
| 85 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.75561900 |
| 86 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75008920 |
| 87 | cellular sodium ion homeostasis (GO:0006883) | 2.74304835 |
| 88 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.73224570 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 2.71790125 |
| 90 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.71072301 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 2.70458749 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 2.68523574 |
| 93 | phospholipid efflux (GO:0033700) | 2.68248952 |
| 94 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.68247464 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67788444 |
| 96 | negative regulation of lipase activity (GO:0060192) | 2.67450893 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.66325008 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 2.66044423 |
| 99 | semaphorin-plexin signaling pathway (GO:0071526) | 2.65750346 |
| 100 | ethanol oxidation (GO:0006069) | 2.64525300 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 2.63766846 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 2.63640378 |
| 103 | dicarboxylic acid catabolic process (GO:0043649) | 2.63535976 |
| 104 | drug transmembrane transport (GO:0006855) | 2.62802995 |
| 105 | lysine metabolic process (GO:0006553) | 2.61365306 |
| 106 | lysine catabolic process (GO:0006554) | 2.61365306 |
| 107 | protein-lipid complex assembly (GO:0065005) | 2.61017456 |
| 108 | bile acid and bile salt transport (GO:0015721) | 2.60841384 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 2.57332777 |
| 110 | cofactor catabolic process (GO:0051187) | 2.56769316 |
| 111 | intestinal cholesterol absorption (GO:0030299) | 2.56461271 |
| 112 | cholesterol metabolic process (GO:0008203) | 2.56377916 |
| 113 | thioester metabolic process (GO:0035383) | 2.56376215 |
| 114 | acyl-CoA metabolic process (GO:0006637) | 2.56376215 |
| 115 | surfactant homeostasis (GO:0043129) | 2.55817811 |
| 116 | regulation of complement activation (GO:0030449) | 2.54497941 |
| 117 | glycerophospholipid catabolic process (GO:0046475) | 2.54283225 |
| 118 | cholesterol homeostasis (GO:0042632) | 2.53096640 |
| 119 | layer formation in cerebral cortex (GO:0021819) | 2.52099837 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 2.51930473 |
| 121 | apical protein localization (GO:0045176) | 2.51692363 |
| 122 | intestinal absorption (GO:0050892) | 2.51608066 |
| 123 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.50731620 |
| 124 | sterol homeostasis (GO:0055092) | 2.50222659 |
| 125 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.49480222 |
| 126 | epithelial cilium movement (GO:0003351) | 2.49139273 |
| 127 | serine family amino acid catabolic process (GO:0009071) | 2.48684974 |
| 128 | iron coordination entity transport (GO:1901678) | 2.48399233 |
| 129 | establishment of skin barrier (GO:0061436) | 2.46425202 |
| 130 | regulation of water loss via skin (GO:0033561) | 2.46271054 |
| 131 | camera-type eye morphogenesis (GO:0048593) | 2.46247308 |
| 132 | cell migration in hindbrain (GO:0021535) | 2.45733268 |
| 133 | water homeostasis (GO:0030104) | 2.45547101 |
| 134 | cellular potassium ion homeostasis (GO:0030007) | 2.43669912 |
| 135 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.43555214 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 2.42782428 |
| 137 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.41521008 |
| 138 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.37946454 |
| 139 | asymmetric protein localization (GO:0008105) | 2.33717715 |
| 140 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.33088453 |
| 141 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.32289477 |
| 142 | positive regulation of synapse maturation (GO:0090129) | 2.31804806 |
| 143 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.29075366 |
| 144 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.29075366 |
| 145 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.28971791 |
| 146 | epoxygenase P450 pathway (GO:0019373) | 2.26545090 |
| 147 | cell-cell junction maintenance (GO:0045217) | 2.26320286 |
| 148 | vocalization behavior (GO:0071625) | 2.26147891 |
| 149 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.25532302 |
| 150 | left/right pattern formation (GO:0060972) | 2.25196396 |
| 151 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.24687126 |
| 152 | one-carbon compound transport (GO:0019755) | 2.24675504 |
| 153 | chemical homeostasis within a tissue (GO:0048875) | 2.24498245 |
| 154 | cell communication involved in cardiac conduction (GO:0086065) | 2.22793516 |
| 155 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.17955538 |
| 156 | phosphate ion transmembrane transport (GO:0035435) | 2.16221017 |
| 157 | establishment of planar polarity (GO:0001736) | 2.16076763 |
| 158 | establishment of tissue polarity (GO:0007164) | 2.16076763 |
| 159 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.14133381 |
| 160 | plasma lipoprotein particle organization (GO:0071827) | 2.13321350 |
| 161 | lateral sprouting from an epithelium (GO:0060601) | 2.11898278 |
| 162 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.11088185 |
| 163 | cell junction maintenance (GO:0034331) | 2.07609705 |
| 164 | actin filament capping (GO:0051693) | 2.07429187 |
| 165 | filopodium assembly (GO:0046847) | 2.07360575 |
| 166 | gap junction assembly (GO:0016264) | 2.07313794 |
| 167 | epithelial cell-cell adhesion (GO:0090136) | 2.07004556 |
| 168 | neuronal ion channel clustering (GO:0045161) | 2.06525522 |
| 169 | receptor recycling (GO:0001881) | 2.05678959 |
| 170 | protein-lipid complex subunit organization (GO:0071825) | 2.05217849 |
| 171 | establishment of apical/basal cell polarity (GO:0035089) | 2.03825320 |
| 172 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.03182364 |
| 173 | regulation of response to osmotic stress (GO:0047484) | 2.02355834 |
| 174 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.01630525 |
| 175 | cellular response to prostaglandin stimulus (GO:0071379) | 2.00836582 |
| 176 | negative regulation of fatty acid transport (GO:2000192) | 2.00428688 |
| 177 | neuron recognition (GO:0008038) | 1.99930916 |
| 178 | low-density lipoprotein particle remodeling (GO:0034374) | 1.99251564 |
| 179 | polyol transport (GO:0015791) | 1.98561587 |
| 180 | proline metabolic process (GO:0006560) | 1.98206559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.72974778 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.67362253 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54674734 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09647639 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75632007 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.39835985 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.36433710 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.30135782 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20543073 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19714121 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.96229404 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.90583743 |
| 13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.86636115 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80094456 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79022673 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78633593 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73919556 |
| 18 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.73448883 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70158522 |
| 20 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69865434 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68018322 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67744372 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64928048 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64928048 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.64485308 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60856795 |
| 27 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57395113 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55851011 |
| 29 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55382103 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55285135 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54662279 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54519578 |
| 33 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52965980 |
| 34 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52205047 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51332094 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49770154 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49305611 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49108552 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46586986 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45587997 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44994530 |
| 42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42354710 |
| 43 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42301396 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40931395 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40372727 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39358008 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37051730 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.35858860 |
| 49 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35202777 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34603943 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34327943 |
| 52 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34029858 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31911707 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29990197 |
| 55 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28237325 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28026126 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27702375 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26796849 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25836647 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25667347 |
| 61 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25597765 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23549778 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23403445 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22788256 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22389533 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21373278 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20775488 |
| 68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20663109 |
| 69 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20304052 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20222671 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18993304 |
| 72 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17457367 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16985884 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15948883 |
| 75 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14597065 |
| 76 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14597065 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11492269 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11334952 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11265915 |
| 80 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11160342 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09789202 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08201959 |
| 83 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07780881 |
| 84 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07239287 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06758015 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06555867 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05868363 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04693519 |
| 89 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04028557 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03675701 |
| 91 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02340117 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02045609 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00718764 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00680030 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00096742 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99514785 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99422615 |
| 98 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99333710 |
| 99 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99135281 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99066145 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98926680 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98540320 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98374636 |
| 104 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98357055 |
| 105 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97493282 |
| 106 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97412539 |
| 107 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96910529 |
| 108 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.96511688 |
| 109 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95843925 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95501273 |
| 111 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95363367 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94263392 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93942909 |
| 114 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93874992 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93854529 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93842864 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93301527 |
| 118 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92702919 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91951676 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91456014 |
| 121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91283114 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91016324 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90747335 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90694375 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90662127 |
| 126 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90227278 |
| 127 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89001685 |
| 128 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88834982 |
| 129 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87148764 |
| 130 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86990372 |
| 131 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86216178 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86210765 |
| 133 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85397960 |
| 134 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.85357545 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85034853 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83485579 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83405206 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83050720 |
| 139 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.82136619 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82009589 |
| 141 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81570858 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.81506194 |
| 143 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80014306 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.79105902 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78741991 |
| 146 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77415682 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76386401 |
| 148 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.76246106 |
| 149 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.76000124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.71814059 |
| 2 | MP0005360_urolithiasis | 4.94114452 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.24670489 |
| 4 | MP0005365_abnormal_bile_salt | 3.83560722 |
| 5 | MP0000566_synostosis | 3.70413714 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.58435096 |
| 7 | MP0005409_darkened_coat_color | 3.31219291 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.92802862 |
| 9 | MP0003195_calcinosis | 2.71790154 |
| 10 | MP0003252_abnormal_bile_duct | 2.71320676 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.68424790 |
| 12 | MP0004270_analgesia | 2.52733804 |
| 13 | MP0000920_abnormal_myelination | 2.49908884 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.48421231 |
| 15 | MP0003329_amyloid_beta_deposits | 2.40265826 |
| 16 | MP0005083_abnormal_biliary_tract | 2.36866219 |
| 17 | MP0003690_abnormal_glial_cell | 2.28559253 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.21642395 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.19971785 |
| 20 | MP0009840_abnormal_foam_cell | 2.19617902 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.18251189 |
| 22 | MP0002796_impaired_skin_barrier | 2.07562374 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.05982277 |
| 24 | MP0003880_abnormal_central_pattern | 2.02809798 |
| 25 | MP0005332_abnormal_amino_acid | 1.87292267 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.80090176 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.79759579 |
| 28 | MP0002098_abnormal_vibrissa_morphology | 1.79227571 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.76576248 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.75933216 |
| 31 | MP0004885_abnormal_endolymph | 1.72123931 |
| 32 | MP0000604_amyloidosis | 1.68012058 |
| 33 | MP0003868_abnormal_feces_composition | 1.67989607 |
| 34 | MP0003878_abnormal_ear_physiology | 1.65086839 |
| 35 | MP0005377_hearing/vestibular/ear_phenot | 1.65086839 |
| 36 | MP0003879_abnormal_hair_cell | 1.61431091 |
| 37 | MP0003122_maternal_imprinting | 1.59596840 |
| 38 | MP0001486_abnormal_startle_reflex | 1.57367797 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.57295127 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.56590380 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.56324853 |
| 42 | MP0002822_catalepsy | 1.52390264 |
| 43 | MP0002064_seizures | 1.48462475 |
| 44 | MP0000383_abnormal_hair_follicle | 1.44425852 |
| 45 | MP0001849_ear_inflammation | 1.42099796 |
| 46 | MP0002249_abnormal_larynx_morphology | 1.41539711 |
| 47 | MP0002272_abnormal_nervous_system | 1.40189633 |
| 48 | MP0004043_abnormal_pH_regulation | 1.39904000 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.38614784 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.38471928 |
| 51 | MP0000778_abnormal_nervous_system | 1.35461208 |
| 52 | MP0009745_abnormal_behavioral_response | 1.34533686 |
| 53 | MP0005501_abnormal_skin_physiology | 1.32337850 |
| 54 | MP0001188_hyperpigmentation | 1.30963209 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.29788490 |
| 56 | MP0004272_abnormal_basement_membrane | 1.29313262 |
| 57 | MP0003634_abnormal_glial_cell | 1.27522707 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.25813404 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.23817012 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 1.21055634 |
| 61 | MP0005451_abnormal_body_composition | 1.20993172 |
| 62 | MP0005423_abnormal_somatic_nervous | 1.19805023 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.19422933 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.18877941 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.15869705 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15483491 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.15334897 |
| 68 | MP0009046_muscle_twitch | 1.14336558 |
| 69 | MP0000609_abnormal_liver_physiology | 1.13947193 |
| 70 | MP0000462_abnormal_digestive_system | 1.13436912 |
| 71 | MP0003632_abnormal_nervous_system | 1.13318865 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.12349844 |
| 73 | MP0004742_abnormal_vestibular_system | 1.09579962 |
| 74 | MP0002229_neurodegeneration | 1.08976295 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.08729475 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.05560653 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.05051308 |
| 78 | MP0000467_abnormal_esophagus_morphology | 1.04327428 |
| 79 | MP0003941_abnormal_skin_development | 1.04278070 |
| 80 | MP0010368_abnormal_lymphatic_system | 1.03964738 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.03361420 |
| 82 | MP0001529_abnormal_vocalization | 1.02869220 |
| 83 | MP0003566_abnormal_cell_adhesion | 1.00119783 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.98674834 |
| 85 | MP0003633_abnormal_nervous_system | 0.98491710 |
| 86 | MP0005499_abnormal_olfactory_system | 0.97941552 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.97941552 |
| 88 | MP0005275_abnormal_skin_tensile | 0.97802712 |
| 89 | MP0000534_abnormal_ureter_morphology | 0.97158346 |
| 90 | MP0003631_nervous_system_phenotype | 0.97096940 |
| 91 | MP0002735_abnormal_chemical_nociception | 0.96978744 |
| 92 | MP0004147_increased_porphyrin_level | 0.96111717 |
| 93 | MP0002254_reproductive_system_inflammat | 0.95647313 |
| 94 | MP0000955_abnormal_spinal_cord | 0.95598907 |
| 95 | MP0000579_abnormal_nail_morphology | 0.93364793 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.93325916 |
| 97 | MP0004142_abnormal_muscle_tone | 0.91540413 |
| 98 | MP0000377_abnormal_hair_follicle | 0.85081972 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.84570396 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.84427786 |
| 101 | MP0010678_abnormal_skin_adnexa | 0.84374646 |
| 102 | MP0002733_abnormal_thermal_nociception | 0.83921195 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.82951667 |
| 104 | MP0005408_hypopigmentation | 0.82877516 |
| 105 | MP0001984_abnormal_olfaction | 0.82541140 |
| 106 | MP0004924_abnormal_behavior | 0.82508543 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.82508543 |
| 108 | MP0002066_abnormal_motor_capabilities/c | 0.81984160 |
| 109 | MP0010771_integument_phenotype | 0.81556749 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.81376850 |
| 111 | MP0003861_abnormal_nervous_system | 0.81291287 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 0.81264836 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.80535225 |
| 114 | MP0002882_abnormal_neuron_morphology | 0.79791049 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.79264235 |
| 116 | MP0001177_atelectasis | 0.77862030 |
| 117 | MP0002067_abnormal_sensory_capabilities | 0.77374330 |
| 118 | MP0005535_abnormal_body_temperature | 0.77198377 |
| 119 | MP0001661_extended_life_span | 0.77078619 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.76950619 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.76726303 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.76317605 |
| 123 | MP0001905_abnormal_dopamine_level | 0.76288360 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.76057548 |
| 125 | MP0002152_abnormal_brain_morphology | 0.75908004 |
| 126 | MP0009053_abnormal_anal_canal | 0.75505373 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.75009465 |
| 128 | MP0001664_abnormal_digestion | 0.74047171 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.73431620 |
| 130 | MP0002090_abnormal_vision | 0.73277063 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.71707944 |
| 132 | MP0005187_abnormal_penis_morphology | 0.71458368 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.70699595 |
| 134 | MP0004858_abnormal_nervous_system | 0.70166832 |
| 135 | MP0001756_abnormal_urination | 0.69681572 |
| 136 | MP0003950_abnormal_plasma_membrane | 0.69586612 |
| 137 | MP0004130_abnormal_muscle_cell | 0.69508955 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.69245175 |
| 139 | MP0005670_abnormal_white_adipose | 0.68413846 |
| 140 | MP0002233_abnormal_nose_morphology | 0.67908396 |
| 141 | MP0003942_abnormal_urinary_system | 0.67685388 |
| 142 | MP0003115_abnormal_respiratory_system | 0.67141714 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.66696886 |
| 144 | MP0008874_decreased_physiological_sensi | 0.65784631 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.65064770 |
| 146 | MP0002557_abnormal_social/conspecific_i | 0.64808817 |
| 147 | MP0000639_abnormal_adrenal_gland | 0.64062268 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.63100669 |
| 149 | MP0001968_abnormal_touch/_nociception | 0.61985386 |
| 150 | MP0001970_abnormal_pain_threshold | 0.61698523 |
| 151 | MP0002069_abnormal_eating/drinking_beha | 0.59832104 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.59581540 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.59339087 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.58927902 |
| 155 | MP0008569_lethality_at_weaning | 0.58887742 |
| 156 | MP0001501_abnormal_sleep_pattern | 0.58701084 |
| 157 | MP0003075_altered_response_to | 0.58055208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.48555081 |
| 2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.30456266 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.20353051 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.12964818 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.69423965 |
| 6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.65445636 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.65445636 |
| 8 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.49681246 |
| 9 | Abnormal ciliary motility (HP:0012262) | 4.46011303 |
| 10 | Xanthomatosis (HP:0000991) | 4.40156982 |
| 11 | Absent/shortened dynein arms (HP:0200106) | 4.38367038 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.38367038 |
| 13 | Rhinitis (HP:0012384) | 4.19987718 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.09027168 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.00505874 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.94446380 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.82393561 |
| 18 | Chronic bronchitis (HP:0004469) | 3.72116331 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.71357341 |
| 20 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.62362701 |
| 21 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.62362701 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.46695331 |
| 23 | Epidermoid cyst (HP:0200040) | 3.31115454 |
| 24 | Ketosis (HP:0001946) | 3.15629350 |
| 25 | Nasal polyposis (HP:0100582) | 3.05567533 |
| 26 | Flat acetabular roof (HP:0003180) | 2.98944830 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93351834 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 2.92039316 |
| 29 | Complement deficiency (HP:0004431) | 2.86678579 |
| 30 | Fat malabsorption (HP:0002630) | 2.85121153 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.83774491 |
| 32 | Bronchomalacia (HP:0002780) | 2.75548271 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.74311987 |
| 34 | Hyperammonemia (HP:0001987) | 2.74206735 |
| 35 | Abnormality of nail color (HP:0100643) | 2.73993760 |
| 36 | Sensory axonal neuropathy (HP:0003390) | 2.72461126 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70780225 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.70780225 |
| 39 | Bronchiectasis (HP:0002110) | 2.69460059 |
| 40 | Hyperglycinemia (HP:0002154) | 2.68034967 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.67976088 |
| 42 | Ketoacidosis (HP:0001993) | 2.67858402 |
| 43 | Spastic gait (HP:0002064) | 2.67448060 |
| 44 | Intention tremor (HP:0002080) | 2.66741379 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.64349094 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63928687 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.62056575 |
| 48 | Myokymia (HP:0002411) | 2.59914773 |
| 49 | Termporal pattern (HP:0011008) | 2.55820623 |
| 50 | Insidious onset (HP:0003587) | 2.55820623 |
| 51 | Hyperventilation (HP:0002883) | 2.54710957 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49983628 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.49197441 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.46444575 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.45486906 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.41906989 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 2.40786897 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.40681624 |
| 59 | Acanthocytosis (HP:0001927) | 2.40257693 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.39710321 |
| 61 | Right ventricular cardiomyopathy (HP:0011663) | 2.39703791 |
| 62 | Joint hemorrhage (HP:0005261) | 2.38689291 |
| 63 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37138855 |
| 64 | Cerebral hemorrhage (HP:0001342) | 2.34127511 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.32521610 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 2.29757186 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.27135510 |
| 68 | Cholecystitis (HP:0001082) | 2.27135510 |
| 69 | Neonatal short-limb short stature (HP:0008921) | 2.25691093 |
| 70 | Hyperbilirubinemia (HP:0002904) | 2.24427379 |
| 71 | Hypophosphatemic rickets (HP:0004912) | 2.23117504 |
| 72 | Hypercholesterolemia (HP:0003124) | 2.20681155 |
| 73 | Hyperkalemia (HP:0002153) | 2.19584710 |
| 74 | Atelectasis (HP:0100750) | 2.19406624 |
| 75 | Infertility (HP:0000789) | 2.19141217 |
| 76 | Aplasia of the phalanges of the hand (HP:0009802) | 2.17489806 |
| 77 | Aplasia involving bones of the extremities (HP:0009825) | 2.17489806 |
| 78 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.17489806 |
| 79 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16267776 |
| 80 | Rickets (HP:0002748) | 2.14452393 |
| 81 | Gout (HP:0001997) | 2.14336285 |
| 82 | Hyperglycinuria (HP:0003108) | 2.14330473 |
| 83 | Pheochromocytoma (HP:0002666) | 2.12750759 |
| 84 | Dysmetria (HP:0001310) | 2.12099579 |
| 85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11285026 |
| 86 | Male infertility (HP:0003251) | 2.11068990 |
| 87 | Bifid scrotum (HP:0000048) | 2.10465189 |
| 88 | Scanning speech (HP:0002168) | 2.10330379 |
| 89 | Abnormality of carpal bone ossification (HP:0006257) | 2.08954278 |
| 90 | Parakeratosis (HP:0001036) | 2.07908609 |
| 91 | Spastic paraparesis (HP:0002313) | 2.07736946 |
| 92 | Akinesia (HP:0002304) | 2.07312997 |
| 93 | Confusion (HP:0001289) | 2.07087848 |
| 94 | Steatorrhea (HP:0002570) | 2.06775656 |
| 95 | Arterial tortuosity (HP:0005116) | 2.05566349 |
| 96 | Symptomatic seizures (HP:0011145) | 2.04213250 |
| 97 | Cholelithiasis (HP:0001081) | 2.04195213 |
| 98 | Atrophic scars (HP:0001075) | 2.03147913 |
| 99 | Onion bulb formation (HP:0003383) | 2.02226761 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02136709 |
| 101 | Vertebral arch anomaly (HP:0008438) | 2.00478793 |
| 102 | Glomerulonephritis (HP:0000099) | 1.99642471 |
| 103 | Skin nodule (HP:0200036) | 1.99550357 |
| 104 | Turricephaly (HP:0000262) | 1.99530799 |
| 105 | Alacrima (HP:0000522) | 1.97701629 |
| 106 | Ankle clonus (HP:0011448) | 1.96539626 |
| 107 | Amyloidosis (HP:0011034) | 1.96224844 |
| 108 | Irritability (HP:0000737) | 1.95216371 |
| 109 | Action tremor (HP:0002345) | 1.94782231 |
| 110 | Megalencephaly (HP:0001355) | 1.94620872 |
| 111 | Increased circulating renin level (HP:0000848) | 1.92953692 |
| 112 | Thin bony cortex (HP:0002753) | 1.91451091 |
| 113 | Alkalosis (HP:0001948) | 1.90456644 |
| 114 | Advanced eruption of teeth (HP:0006288) | 1.90077872 |
| 115 | Clonus (HP:0002169) | 1.88287993 |
| 116 | Germ cell neoplasia (HP:0100728) | 1.87565677 |
| 117 | Abnormality of chloride homeostasis (HP:0011422) | 1.86805672 |
| 118 | Spastic tetraparesis (HP:0001285) | 1.85877958 |
| 119 | Peripheral hypomyelination (HP:0007182) | 1.85495412 |
| 120 | Hepatoblastoma (HP:0002884) | 1.85272001 |
| 121 | Ulnar bowing (HP:0003031) | 1.83500134 |
| 122 | Vascular calcification (HP:0004934) | 1.82913580 |
| 123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82517135 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 1.81773295 |
| 125 | Metabolic acidosis (HP:0001942) | 1.80942374 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 1.80625773 |
| 127 | Hypsarrhythmia (HP:0002521) | 1.80356661 |
| 128 | Abnormality of purine metabolism (HP:0004352) | 1.78503123 |
| 129 | Abnormality of the aortic arch (HP:0012303) | 1.77885482 |
| 130 | Paraparesis (HP:0002385) | 1.77199646 |
| 131 | Vascular tortuosity (HP:0004948) | 1.77179008 |
| 132 | Hypochromic microcytic anemia (HP:0004840) | 1.76972250 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.76955700 |
| 134 | Poikilocytosis (HP:0004447) | 1.76911558 |
| 135 | Hypokalemic alkalosis (HP:0001949) | 1.76887891 |
| 136 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76216902 |
| 137 | Shallow orbits (HP:0000586) | 1.76043896 |
| 138 | Protuberant abdomen (HP:0001538) | 1.75494146 |
| 139 | Delayed myelination (HP:0012448) | 1.74957346 |
| 140 | Ileus (HP:0002595) | 1.74709520 |
| 141 | Neuroendocrine neoplasm (HP:0100634) | 1.73833236 |
| 142 | Spontaneous abortion (HP:0005268) | 1.73761569 |
| 143 | Abnormality of the dental root (HP:0006486) | 1.73610452 |
| 144 | Taurodontia (HP:0000679) | 1.73610452 |
| 145 | Abnormality of permanent molar morphology (HP:0011071) | 1.73610452 |
| 146 | Laryngomalacia (HP:0001601) | 1.73518846 |
| 147 | Torticollis (HP:0000473) | 1.73288528 |
| 148 | Status epilepticus (HP:0002133) | 1.73111125 |
| 149 | Sensorimotor neuropathy (HP:0007141) | 1.72992928 |
| 150 | Recurrent otitis media (HP:0000403) | 1.72744509 |
| 151 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.71768230 |
| 152 | Hyperparathyroidism (HP:0000843) | 1.69649228 |
| 153 | Abnormal ossification of hand bones (HP:0005921) | 1.67441759 |
| 154 | Abnormal hand bone ossification (HP:0010660) | 1.66748408 |
| 155 | Hyperaldosteronism (HP:0000859) | 1.65054559 |
| 156 | Abnormality of complement system (HP:0005339) | 1.63643312 |
| 157 | Lip pit (HP:0100267) | 1.63501240 |
| 158 | Hand muscle atrophy (HP:0009130) | 1.63014683 |
| 159 | Pili torti (HP:0003777) | 1.63011765 |
| 160 | Milia (HP:0001056) | 1.62392649 |
| 161 | Osteomalacia (HP:0002749) | 1.62333982 |
| 162 | Upper limb amyotrophy (HP:0009129) | 1.62111578 |
| 163 | Distal upper limb amyotrophy (HP:0007149) | 1.62111578 |
| 164 | Hyponatremia (HP:0002902) | 1.60016835 |
| 165 | Renal tubular acidosis (HP:0001947) | 1.59842915 |
| 166 | Abnormality of sodium homeostasis (HP:0010931) | 1.58706837 |
| 167 | Widely patent fontanelles and sutures (HP:0004492) | 1.57834238 |
| 168 | Abnormality of molar morphology (HP:0011070) | 1.57698334 |
| 169 | Abnormality of molar (HP:0011077) | 1.57698334 |
| 170 | Abnormality of the dental pulp (HP:0006479) | 1.56718924 |
| 171 | Broad metatarsal (HP:0001783) | 1.55177042 |
| 172 | Malnutrition (HP:0004395) | 1.54734671 |
| 173 | Hammertoe (HP:0001765) | 1.54687186 |
| 174 | Partial duplication of thumb phalanx (HP:0009944) | 1.52185583 |
| 175 | Systemic lupus erythematosus (HP:0002725) | 1.51474918 |
| 176 | Abnormality of renin-angiotensin system (HP:0000847) | 1.51394451 |
| 177 | Papillary thyroid carcinoma (HP:0002895) | 1.50789372 |
| 178 | Cutaneous finger syndactyly (HP:0010554) | 1.48514212 |
| 179 | Hypoplasia of dental enamel (HP:0006297) | 1.47281034 |
| 180 | Abnormality of the salivary glands (HP:0010286) | 1.45500665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.11325239 |
| 2 | RIPK1 | 3.61440636 |
| 3 | OXSR1 | 3.22111260 |
| 4 | TRIB3 | 3.00601992 |
| 5 | EPHB1 | 2.80615599 |
| 6 | EPHA2 | 2.68259409 |
| 7 | EPHA4 | 2.62693420 |
| 8 | MARK1 | 2.44181460 |
| 9 | FGFR2 | 2.30651894 |
| 10 | WNK4 | 2.28302892 |
| 11 | CDK12 | 2.16112719 |
| 12 | INSRR | 2.08698280 |
| 13 | ICK | 2.07905455 |
| 14 | EEF2K | 2.07372560 |
| 15 | TNIK | 2.04416493 |
| 16 | NTRK1 | 2.03013595 |
| 17 | PKN1 | 1.92934795 |
| 18 | BCR | 1.85287354 |
| 19 | MET | 1.83658043 |
| 20 | CAMK1D | 1.77216858 |
| 21 | PAK6 | 1.70435662 |
| 22 | TYRO3 | 1.68229076 |
| 23 | MAP3K9 | 1.64910023 |
| 24 | DAPK2 | 1.60790096 |
| 25 | MAP3K2 | 1.60537473 |
| 26 | ERBB4 | 1.58102539 |
| 27 | SMG1 | 1.53826712 |
| 28 | FGFR3 | 1.47967687 |
| 29 | PDGFRA | 1.46962030 |
| 30 | PAK3 | 1.46259718 |
| 31 | PKN2 | 1.37750294 |
| 32 | SIK2 | 1.36750559 |
| 33 | CSNK1G2 | 1.34491913 |
| 34 | SIK1 | 1.34466904 |
| 35 | LATS2 | 1.32193855 |
| 36 | WNK1 | 1.30513495 |
| 37 | NTRK3 | 1.28385446 |
| 38 | KSR2 | 1.28363192 |
| 39 | CSNK1A1L | 1.28240073 |
| 40 | SGK223 | 1.27463176 |
| 41 | SGK494 | 1.27463176 |
| 42 | TAOK1 | 1.26426719 |
| 43 | UHMK1 | 1.25608568 |
| 44 | CSNK1G3 | 1.25336816 |
| 45 | PHKG1 | 1.25281623 |
| 46 | PHKG2 | 1.25281623 |
| 47 | BCKDK | 1.25049100 |
| 48 | EPHA3 | 1.24351553 |
| 49 | SGK2 | 1.24011588 |
| 50 | MAP2K4 | 1.23509634 |
| 51 | CDK19 | 1.21191421 |
| 52 | NTRK2 | 1.19343492 |
| 53 | MAP3K4 | 1.14241597 |
| 54 | DYRK1B | 1.14140965 |
| 55 | PRPF4B | 1.11337688 |
| 56 | MAPK15 | 1.10696558 |
| 57 | CDK5 | 1.09367726 |
| 58 | CSNK1G1 | 1.08038953 |
| 59 | CAMK2B | 1.05441304 |
| 60 | FGFR4 | 1.05391735 |
| 61 | AKT3 | 1.04985165 |
| 62 | DDR2 | 1.02505424 |
| 63 | TAOK3 | 1.02408446 |
| 64 | ERN1 | 1.02204918 |
| 65 | CASK | 0.97013127 |
| 66 | MTOR | 0.95142685 |
| 67 | MAPKAPK3 | 0.94462257 |
| 68 | MAP3K10 | 0.94087923 |
| 69 | MAP3K13 | 0.92352452 |
| 70 | ROCK2 | 0.91059976 |
| 71 | CAMK2G | 0.89982772 |
| 72 | LMTK2 | 0.87840258 |
| 73 | CAMK2D | 0.87553159 |
| 74 | RET | 0.86928644 |
| 75 | MINK1 | 0.86330141 |
| 76 | CDC42BPA | 0.82836672 |
| 77 | PTK2 | 0.81781180 |
| 78 | IRAK2 | 0.81514803 |
| 79 | CAMK1G | 0.79168806 |
| 80 | PDPK1 | 0.78295409 |
| 81 | CAMK2A | 0.78293177 |
| 82 | NEK6 | 0.78056890 |
| 83 | MARK2 | 0.77815486 |
| 84 | MAPKAPK5 | 0.76800931 |
| 85 | RPS6KA2 | 0.76273111 |
| 86 | MAPK13 | 0.75999104 |
| 87 | STK11 | 0.75341737 |
| 88 | BRD4 | 0.73932885 |
| 89 | STK38 | 0.73391436 |
| 90 | LIMK1 | 0.72609762 |
| 91 | FGR | 0.71599769 |
| 92 | PRKD3 | 0.71013181 |
| 93 | PRKCZ | 0.70987548 |
| 94 | PRKCQ | 0.69440771 |
| 95 | GSK3A | 0.69356228 |
| 96 | PRKAA2 | 0.67904135 |
| 97 | ERBB2 | 0.66021481 |
| 98 | DYRK2 | 0.65924278 |
| 99 | PRKCE | 0.64401072 |
| 100 | DMPK | 0.64338280 |
| 101 | KSR1 | 0.62989202 |
| 102 | MAP3K3 | 0.62807938 |
| 103 | MAP2K7 | 0.61427695 |
| 104 | MAP3K1 | 0.60910561 |
| 105 | LATS1 | 0.60795655 |
| 106 | PRKCH | 0.60230734 |
| 107 | PIK3CA | 0.59699037 |
| 108 | IRAK1 | 0.59078923 |
| 109 | FYN | 0.58045918 |
| 110 | MST1R | 0.57033892 |
| 111 | PTK6 | 0.56887909 |
| 112 | PNCK | 0.55385070 |
| 113 | MAP3K6 | 0.55335126 |
| 114 | MAP3K7 | 0.55164772 |
| 115 | MAPK10 | 0.54942045 |
| 116 | PRKD1 | 0.54761566 |
| 117 | PBK | 0.54203032 |
| 118 | CDK14 | 0.53749017 |
| 119 | PRKAA1 | 0.53184991 |
| 120 | PRKCG | 0.52219486 |
| 121 | EPHB2 | 0.51676331 |
| 122 | SGK1 | 0.51025683 |
| 123 | YES1 | 0.50670202 |
| 124 | STK24 | 0.48513308 |
| 125 | PDGFRB | 0.47712857 |
| 126 | CAMKK1 | 0.47331360 |
| 127 | BMX | 0.47231407 |
| 128 | HIPK2 | 0.47143671 |
| 129 | CDK15 | 0.45886380 |
| 130 | PRKACG | 0.45230385 |
| 131 | ROCK1 | 0.44655680 |
| 132 | ABL2 | 0.43823633 |
| 133 | SGK3 | 0.43823401 |
| 134 | FER | 0.43100202 |
| 135 | MAP2K1 | 0.42887593 |
| 136 | FGFR1 | 0.42670478 |
| 137 | ARAF | 0.42529538 |
| 138 | CDK6 | 0.41074278 |
| 139 | RPS6KB1 | 0.40865497 |
| 140 | MAPK8 | 0.38215337 |
| 141 | DYRK1A | 0.36917206 |
| 142 | ACVR1B | 0.36070261 |
| 143 | GSK3B | 0.35666288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52238784 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.21328511 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.95400305 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.63537693 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.60140458 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.58309723 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34090903 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.26865021 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25246442 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17026586 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07685169 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02529409 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01876027 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98071823 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88041607 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.84814578 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79344304 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78595706 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76614825 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67350882 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64197175 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63705927 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.60006023 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.56525017 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55368228 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54421216 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51097393 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49102201 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47463172 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43502951 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28327346 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28042509 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27168152 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21366593 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20258249 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19379489 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15896616 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.15565623 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.13631039 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13345704 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.12287550 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08117059 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06866144 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 1.04542802 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04502275 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.01947332 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99567733 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98849717 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97454446 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96108796 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95956296 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94407161 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94011715 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93492780 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92901451 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91962571 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90219509 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86727120 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86531356 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85737105 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85459472 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83975875 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79792720 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78983211 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78300670 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75627170 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.74358393 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74174514 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73090344 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72507638 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71261866 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70939714 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69190728 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68488734 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68385729 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66653602 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.66485728 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65963543 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.65941709 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65785965 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65370551 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.65094434 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64793422 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.64552667 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64461998 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63343981 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63260041 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61939835 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61886187 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60322975 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60030255 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.59191427 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58564455 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.57180738 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55989808 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55786860 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55202539 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55028075 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54484152 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.54376791 |
| 101 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54141035 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53568896 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52851159 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.52109310 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51600270 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51318044 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50743799 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50141932 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.49654305 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48963030 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.45967436 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45320829 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44926722 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42685773 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42371058 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39493826 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39231157 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38989467 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38540564 |
| 120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38274353 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37848524 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.37798980 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37790079 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37549755 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36062302 |
| 126 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.34996870 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32890281 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32144215 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31411671 |
| 130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30796131 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30777360 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30198082 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.29908490 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29658753 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28635584 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28171566 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28163980 |
| 138 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27367905 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26976532 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.26334375 |
| 141 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24069524 |

